This article discusses how the India based Lupin company just received approval from the USFDA to produce a generic form of the drug Epivir. This news impacts me, I take the generic form known as Lamivudine. I'm not sure what this will mean for me, if anything.
On another note, I waited all day Christmas Eve for my meds to arrive. They didn't. I couldn't call the pharmacy until today. They failed to tell me they needed refills. Something I could've handled when they called when they made the order. My doctor is out until Monday. I might have my order in a week or so. Luckily I wasn't low on anything. CVS Caremark is back to sucking.
Well, it's December 26th & I'm exhausted. I've had all the holidays I can stand. I've had my fill of December & 2014. For now, I'm staying inside & doing as little as possible. Have a good ending to the year.
Cya...
ReplyDeleteLupine Ltd., still regarded as a good stock. The entire pharma sector is facing a crisis because of the USFDA. The stock has been performing like Lupine for a few years now.